Literature DB >> 8665497

Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness.

S Shimoyama1, F Gansauge, S Gansauge, G Negri, T Oohara, H G Beger.   

Abstract

We have investigated the expression of angiogenin (ANG) in pancreatic cancer and the relevance of ANG expression to the progression of pancreatic cancer. In comparison to normal pancreas, increased ANG mRNA expression was observed in 80.0% of the cases of pancreatic cancer by in situ hybridization, and increased ANG protein expression was observed in 86.7% of the cases of pancreatic cancer using Western blot analysis. The mean serum ANG concentration of pancreatic cancer patients (566.6 +/- 191.9 ng/ml) was significantly higher (P < 2.0 x 10(-8)) than that of healthy volunteers (359.0 +/-t 59.9 ng/ml). Increased ANG mRNA expression as well as elevated serum ANG concentration correlated with poor prognosis. These findings suggest that ANG expression is up-regulated in pancreatic cancer patients and that ANG contributes to the aggressiveness of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665497

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  Mechanism and Function of Angiogenin in Hematopoietic Malignancy.

Authors:  Kevin A Goncalves; Guo-Fu Hu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-23

3.  A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation.

Authors:  Norie Yoshioka; Li Wang; Koji Kishimoto; Takanori Tsuji; Guo-fu Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

4.  Angiogenin as a molecular target for the treatment of prostate cancer.

Authors:  Shuping Li; Soichiro Ibaragi; Guo-Fu Hu
Journal:  Curr Cancer Ther Rev       Date:  2011-05

5.  Angiogenin in sera as an independent prognostic factor in gastric cancer.

Authors:  Shouji Shimoyama; Michio Kaminishi
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-08       Impact factor: 4.553

6.  Neamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferation.

Authors:  Koji Kishimoto; Shoko Yoshida; Soichiro Ibaragi; Norie Yoshioka; Guo-Fu Hu; Akira Sasaki
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

7.  Selective abolition of pancreatic RNase binding to its inhibitor protein.

Authors:  Kapil Kumar; Michael Brady; Robert Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

Review 8.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Neomycin inhibits angiogenin-induced angiogenesis.

Authors:  G F Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.

Authors:  Soichiro Ibaragi; Norie Yoshioka; Shuping Li; Miaofen G Hu; Saori Hirukawa; Peter M Sadow; Guo-Fu Hu
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.